Philip Morris International (PM)
Sells Marlboro cigarettes and IQOS, ZYN, and VEEV smoke-free products.
$191.03
vs last close+0.79 (+0.42%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9,141 | 9,047 | 8,793 | 9,468 | 9,911 | 9,706 | 9,301 | 10,140 | 10,845 | 10,362 | 10,146 | 11,192 |
| Cost of revenue | 3,154 | 3,426 | 3,195 | 3,345 | 3,366 | 3,423 | 3,040 | 3,279 | 3,487 | 3,560 | 3,241 | 3,533 |
| Gross profit | 5,987 | 5,621 | 5,598 | 6,123 | 6,545 | 6,283 | 6,261 | 6,861 | 7,358 | 6,802 | 6,905 | 7,659 |
| 2,606 | 2,732 | 2,553 | 2,679 | 2,891 | 3,024 | 2,717 | 3,108 | 3,095 | 3,429 | 3,012 | 3,129 | |
| 2,614 | 2,031 | 2,769 | 2,371 | 2,891 | 3,024 | 2,717 | 3,108 | 3,095 | 3,429 | 2,857 | 2,981 | |
| Selling & marketing | 0 | 0 | 201 | −322 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 2,614 | 2,031 | 2,568 | 2,693 | 2,891 | 3,024 | 0 | 0 | 0 | 0 | 2,857 | 0 |
| Other expenses | −8 | 701 | −216 | 308 | 0 | 0 | 0 | 0 | 0 | 0 | 155 | 148 |
| Operating income | 3,370 | 2,889 | 3,045 | 3,444 | 3,654 | 3,259 | 3,544 | 3,753 | 4,263 | 3,373 | 3,893 | 4,530 |
| −168 | −256 | −123 | −182 | 296 | −1,194 | −48 | 47 | 101 | −448 | −635 | −238 | |
| Interest income | 0 | 465 | 0 | 0 | 0 | 620 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 261 | 738 | 299 | 329 | 189 | 946 | 241 | 277 | 230 | 839 | 237 | 243 |
| Other non-operating income | 8 | −800 | 15 | 14 | 15 | −604 | 12 | 52 | 14 | −612 | −5 | −5 |
| Income before tax | 3,202 | 2,633 | 2,922 | 3,262 | 3,950 | 2,065 | 3,496 | 3,800 | 4,364 | 2,925 | 3,258 | 4,292 |
| Income tax expense | 1,031 | 320 | 676 | 734 | 735 | 235 | 659 | 652 | 751 | 675 | 676 | 955 |
| Net income from continuing operations | 2,171 | 2,313 | 2,246 | 2,528 | 3,215 | 1,830 | 2,837 | 3,148 | 3,613 | 2,250 | 2,582 | 3,337 |
| Discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | −2,316 | 0 | 0 | 0 | 0 | 0 | −370 |
| Net income | 2,054 | 2,196 | 2,148 | 2,406 | 3,082 | −579 | 2,690 | 3,039 | 3,478 | 2,141 | 2,438 | 2,817 |
| EPS, basic | $1.32 | $1.41 | $1.38 | $1.54 | $1.98 | −$0.37 | $1.72 | $1.95 | $2.23 | $1.37 | $1.56 | $1.80 |
| EPS, diluted | $1.32 | $1.41 | $1.38 | $1.54 | $1.97 | −$0.37 | $1.72 | $1.95 | $2.23 | $1.37 | $1.56 | $1.80 |
| Weighted average shares, basic | 1,552 | 1,552 | 1,553 | 1,555 | 1,555 | 1,554 | 1,554 | 1,557 | 1,557 | 1,557 | 1,563 | 1,563 |
| Weighted average shares, diluted | 1,554 | 1,554 | 1,555 | 1,556 | 1,556 | 1,556 | 1,556 | 1,558 | 1,558 | 1,558 | 1,563 | 1,563 |
| EBITDA | 3,791 | 4,058 | 3,397 | 3,875 | 4,137 | 4,340 | 4,012 | 4,191 | 4,754 | 4,506 | 4,408 | 4,535 |
| Depreciation & amortization | 429 | 369 | 367 | 445 | 498 | 477 | 480 | 490 | 505 | 521 | 510 | 0 |
| EBIT | 3,362 | 3,689 | 3,030 | 3,430 | 3,639 | 3,863 | 3,532 | 3,701 | 4,249 | 3,985 | 3,898 | 4,535 |